Effects of low-dose d-serine on recognition and working memory in mice

Psychopharmacology

Volumn 218, Issue 3, 2011, Pages 461-470

  Bado, Patricia ^a,b   Madeira, Caroline ^a   Vargas Lopes, Charles ^a   Moulin, Thiago C ^a   Wasilewska Sampaio, Ana Paula ^a   Maretti, Luise ^a   De Oliveira, Ricardo V ^a   Amaral, Olavo B ^a   Panizzutti, Rogério ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

Author keywords

d Serine; Memory; NMDA receptor; Object recognition; T maze

Indexed keywords

CYCLOSERINE; DEXTRO SERINE; DIZOCILPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG EFFECT; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; LEARNING DISORDER; LOW DRUG DOSE; MALE; MAZE TEST; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; MOUSE; NONHUMAN; OPEN FIELD TEST; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RECOGNITION; SCHIZOPHRENIA; SHORT TERM MEMORY; SYSTEMIC THERAPY; WORKING MEMORY;

ANIMALS; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSERINE; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED BALB C; RECEPTORS, N-METHYL-D-ASPARTATE; RECOGNITION (PSYCHOLOGY); SERINE; TIME FACTORS;

EID: 82955237484     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2330-4     Document Type: Article

References (60)

1. I Akirav M Maroun 2006 Ventromedial prefrontal cortex is obligatory for consolidation and reconsolidation of object recognition memory Cereb Cortex 16 1759 1765 16421330 10.1093/cercor/bhj114 (Pubitemid 44729914)
2. FL Assini M Duzzioni RN Takahashi 2009 Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation Behav Brain Res 204 206 211 19523494 10.1016/j.bbr.2009.06.005 1:CAS:528:DC%2BD1MXpsFynsLk%3D
3. I Bendikov C Nadri S Amar R Panizzutti J De Miranda H Wolosker G Agam 2007 A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia Schizophr Res 90 41 51 17156977 10.1016/j.schres.2006.10.010 (Pubitemid 46177566)
4. JL Brigman J Ihne LM Saksida TJ Bussey A Holmes 2009 Effects of subchronic phencyclidine (PCP) treatment on social behaviors, and operant discrimination and reversal learning in C57BL/6J mice Front Behav Neurosci 3 2 19255630 10.3389/neuro.08.002.2009
5. SP Brooks T Pask L Jones SB Dunnett 2005 Behavioural profiles of inbred mouse strains used as transgenic backgrounds. II. Cognitive tests Genes Brain Behav 4 307 317 16011577 10.1111/j.1601-183X.2004.00109.x 1:STN:280: DC%2BD2MzlvVWqsw%3D%3D (Pubitemid 41002406)
6. JT Coyle 1996 The glutamatergic dysfunction hypothesis for schizophrenia Harv Rev Psychiatry 3 241 253 9384954 10.3109/10673229609017192 1:STN:280:DyaK1c%2Fjs1yktQ%3D%3D (Pubitemid 26058365)
7. MNM de Lima DC Laranja E Bromberg R Roesler N Schröder 2005 Pre- or post- training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats Behav Brain Res 156 139 143 15474658 10.1016/j.bbr.2004.05.016 (Pubitemid 39330444)
8. S Duffy V Labrie JC Roder 2008 D-Serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning Neuropsychopharmacology 33 1004 1018 17625504 10.1038/sj.npp.1301486 1:CAS:528:DC%2BD1cXjtFOhtLg%3D (Pubitemid 351367543)
9. RJ Fishkin EC Ince WA Carlezon RW Dunn 1993 D-Cycloserine attenuates scopolamine-induced learning and memory deficits in rats Behav Neural Biol 59 150 157 8476382 10.1016/0163-1047(93)90886-M 1:CAS:528:DyaK3sXks1art70%3D (Pubitemid 23131175)
10. BS Folley R Astur K Jagannathan VD Calhoun GD Pearlson 2010 Anomalous neural circuit function in schizophrenia during a virtual Morris water task Neuroimage 49 3373 3384 19948225 10.1016/j.neuroimage.2009.11.034
11. DC Goff C Cather JD Gottlieb AE Evins J Walsh L Raeke MW Otto D Schoenfeld MF Green 2008 Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study Schizophr Res 106 320 327 18799288 10.1016/j.schres.2008.08.012
12. MF Green 1996 What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153 321 330 8610818 1:STN:280:DyaK287otVGqtA%3D%3D (Pubitemid 26074706)
13. MF Green RS Kern RK Heaton 2004 Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS Schizophr Res 72 41 51 15531406 10.1016/j.schres.2004.09.009 (Pubitemid 39452904)
14. G Habl M Zink G Petroianu M Bauer T Schneider-Axmann M von Wilmsdorff P Falkai F Henn A Schmitt 2009 Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study J Neural Transm 116 1657 1665 19823762 10.1007/s00702-009-0312-z 1:CAS:528:DC%2BD1MXhsVWqu7rE
15. A Hashimoto T Nishikawa T Oka K Takahashi T Hayashi 1992 Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert.-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde J Chromatogr 6 41 48
16. K Hashimoto T Fukushima E Shimizu N Komatsu H Watanabe N Shinoda M Nakazato C Kumakiri O S-i H Hasegawa K Imai M Iyo 2003 Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D- aspartate receptor hypofunction hypothesis of schizophrenia Arch Gen Psychiatry 60 572 576 12796220 10.1001/archpsyc.60.6.572 1:CAS:528:DC%2BD3sXltlKht74%3D (Pubitemid 36682314)
17. K Hashimoto G Engberg E Shimizu C Nordin LH Lindström M Iyo 2005 Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients Prog Neuropsychopharmacol Biol Psychiatry 29 767 769 15939521 10.1016/j.pnpbp.2005.04.023 1:CAS:528:DC%2BD2MXlslymtbk%3D (Pubitemid 40897791)
18. K Hashimoto Y Fujita T Ishima S Chaki M Iyo 2008 Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine Eur Neuropsychopharmacol 18 414 421 17804206 10.1016/j.euroneuro.2007.07.009 1:CAS:528:DC%2BD1cXlsFOiu74%3D (Pubitemid 351608551)
19. K Hashimoto Y Fujita M Horio S Kunitachi M Iyo D Ferraris T Tsukamoto 2009 Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine Biol Psychiatry 65 1103 1106 19217074 10.1016/j.biopsych.2009.01.002 1:CAS:528:DC%2BD1MXms1Oqtbk%3D
20. C Henneberger T Papouin SHR Oliet DA Rusakov 2010 Long-term potentiation depends on release of D-serine from astrocytes Nature 463 232 236 20075918 10.1038/nature08673 1:CAS:528:DC%2BC3cXntVCrsg%3D%3D
21. U Heresco-Levy DC Javitt R Ebstein A Vass P Lichtenberg G Bar S Catinari M Ermilov 2005 D-Serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia Biol Psychiatry 57 577 585 15780844 10.1016/j.biopsych.2004.12.037 1:CAS:528:DC%2BD2MXisVWqs70%3D (Pubitemid 40409697)
22. I Izquierdo LRM Bevilaqua JI Rossato JS Bonini JH Medina M Cammarota 2006 Different molecular cascades in different sites of the brain control memory consolidation Trends Neurosci 29 496 505 16872686 10.1016/j.tins.2006.07.005 1:CAS:528:DC%2BD28XptVGntLw%3D (Pubitemid 44291818)
23. J Jentsch R Roth 1999 The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 201 225 10063482 10.1016/S0893-133X(98)00060-8 1:CAS:528:DyaK1MXhsleisrs%3D (Pubitemid 29067401)
24. N Kanahara E Shimizu S Ohgake Y Fujita M Kohno T Hashimoto D Matsuzawa Y Shirayama K Hashimoto M Iyo 2008 Glycine and D-serine, but not D-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801 Psychopharmacology 198 363 374 18437299 10.1007/s00213-008-1151-6 1:CAS:528:DC%2BD1cXmtFems7Y%3D
25. JT Kantrowitz AK Malhotra B Cornblatt G Silipo A Balla RF Suckiw C D'Souza J Saksa SW Woods DC Javitt 2010 High dose D-serine in the treatment of schizophrenia Schizophr Res 121 125 130 20541910 10.1016/j.schres.2010.05.012
26. J Karasawa K Hashimoto S Chaki 2008 D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats Behav Brain Res 186 78 83 17854919 10.1016/j.bbr.2007. 07.033 1:CAS:528:DC%2BD2sXhtlalsrzP (Pubitemid 350100896)
27. E Kart-Teke MA De Souza Silva P Joseph JP Huston E Dere 2006 Wistar rats show episodic-like memory for unique experiences Neurobiol Learn Mem 85 173 182 16290193 10.1016/j.nlm.2005.10.002 (Pubitemid 43247843)
28. RS Keefe RM Bilder SM Davis PD Harvey BW Palmer JM Gold HY Meltzer MF Green G Capuano TS Stroup JP McEvoy MS Swartz RA Rosenheck DO Perkins CE Davis JK Hsiao JA Lieberman 2007 Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial Arch Gen Psychiatry 64 633 647 17548746 10.1001/archpsyc.64.6.633 1:CAS:528:DC%2BD2sXntlOgtLk%3D (Pubitemid 46878665)
29. LV Kristiansen I Huerta M Beneyto JH Meador-Woodruff 2007 NMDA receptors and schizophrenia Curr Opin Pharmacol 7 48 55 17097347 10.1016/j.coph.2006.08. 013 1:CAS:528:DC%2BD2sXntlGiug%3D%3D
30. V Labrie SJ Clapcote JC Roder 2009 Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors Pharmacol Biochem Behav 91 610 620 18940194 10.1016/j.pbb.2008.09.016 1:CAS:528:DC%2BD1MXhtFegtrg%3D
31. T Lipina L Labrie I Weiner J Roder 2005 Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia Psychopharmacology 179 54 67 15759151 10.1007/s00213-005-2210-x 1:CAS:528:DC%2BD2MXjtV2iurw%3D (Pubitemid 40576692)
32. C Madeira ME Freitas C Vargas-Lopes H Wolosker R Panizzutti 2008 Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia Schizophr Res 101 76 83 18378121 10.1016/j.schres.2008.02.002
33. RC Meyer J Knox DA Purwin EL Spangler DK Ingram 1998 Combined stimulation of the glycine and polyamine sites of the NMDA receptor attenuates NMDA blockade-induced learning deficits of rats in a 14-unit T-maze Psychopharmacology 135 290 295 9498733 10.1007/s002130050512 1:CAS:528:DyaK1cXhtFCkur4%3D (Pubitemid 28055465)
34. J-P Mothet AT Parent H Wolosker RO Brady DJ Linden CD Ferris MA Rogawski SH Snyder 2000 D-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor Proc Natl Acad Sci USA 97 4926 4931 10781100 10.1073/pnas.97.9.4926 1:CAS:528:DC%2BD3cXivFKisrw%3D (Pubitemid 30238659)
35. A Mouri Y Noda T Enomoto T Nabeshima 2007 Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment Neurochem Int 51 173 184 17669558 10.1016/j.neuint.2007.06. 019 1:CAS:528:DC%2BD2sXosFOhurk%3D (Pubitemid 47176714)
36. K Nakazawa TJ McHugh MA Wilson S Tonegawa 2004 NMDA receptors, place cells and hippocampal spatial memory Nat Rev Neurosci 5 361 372 15100719 10.1038/nrn1385 1:CAS:528:DC%2BD2cXjt1ClsLg%3D (Pubitemid 38568497)
37. JC Neill S Barnes S Cook B Grayson NF Idris SL McLean S Snigdha L Rajagopal MK Harte 2010 Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism Pharmacol Ther 128 419 432 20705091 10.1016/j.pharmthera.2010.07.004 1:CAS:528:DC%2BC3cXhtlKhs7%2FK
38. M Nilsson A Carlsson ML Carlsson 1997 Glycine and D-serine decrease MK-801-induced hyperactivity in mice J Neural Transm 104 1195 1205 9503265 10.1007/BF01294720 1:CAS:528:DyaK1cXhtlOlsrY%3D (Pubitemid 28031813)
39. R Panizzutti M Rausch S Zurbrügg D Baumann N Beckmann M Rudin 2005 The pharmacological stimulation of NMDA receptors via co-agonist site: an fMRI study in the rat brain Neurosci Lett 380 111 115 15854761 10.1016/j.neulet.2005. 01.062 1:CAS:528:DC%2BD2MXjs1Ghsb8%3D (Pubitemid 40602339)
40. AS Parnas M Weber R Richardson 2005 Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats Neurobiol Learn Mem 83 224 231 15820858 10.1016/j.nlm.2005.01.001 1:CAS:528:DC%2BD2MXjtVyrt78%3D (Pubitemid 40488810)
41. D Quartermain J Mower MF Rafferty RL Hertng TH Lanthorn 1994 Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention Eur J Pharmacol 257 7 12 8082709 10.1016/0014-2999(94)90687-4 1:CAS:528:DyaK2cXktVWltb0%3D (Pubitemid 24178543)
42. G Riedel B Platt J Micheau 2003 Glutamate receptor function in learning and memory Behav Brain Res 140 1 47 12644276 10.1016/S0166-4328(02)00272-3 1:CAS:528:DC%2BD3sXitV2ht70%3D (Pubitemid 36313239)
43. JI Rossato JS Bonini AS Coitinho MR Vianna JH Medina M Cammarota I Izquierdo 2004 Retrograde amnesia induced by drugs acting on different molecular systems Behav Neurosci 3 563 568 10.1037/0735-7044.118.3.563 (Pubitemid 38685323)
44. ML Schmitt W Coelho AS Lopes-de-Souza FS Guimarães AP Carobrez 1995 Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats Neurosci Lett 189 93 96 7609926 10.1016/0304-3940(95)11459-A 1:CAS:528:DyaK2MXltV2jt7w%3D
45. T Shimazaki A Kaku S Chaki 2010 D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats Psychopharmacology 209 263 270 20198471 10.1007/s00213-010-1794-y 1:CAS:528:DC%2BC3cXis1ersb4%3D
46. E Shimizu Y-P Tang C Rampon JZ Tsien 2000 NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation Science 290 1170 1174 11073458 10.1126/science.290.5494.1170 1:CAS:528:DC%2BD3cXotVChtLk%3D
47. A Sik P van Nieuwehuyzen J Prickaerts A Blokland 2003 Performance of different mouse strains in an object recognition task Behav Brain Res 147 49 54 14659569 10.1016/S0166-4328(03)00117-7 (Pubitemid 37491412)
48. AE Steffek V Haroutunian JH Meador-Woodruff 2006 Serine racemase protein expression in cortex and hippocampus in schizophrenia Neuroreport 17 1181 1185 16837850 10.1097/01.wnr.0000230512.01339.72 1:CAS:528:DC%2BD28XmvFalt7c%3D (Pubitemid 44051409)
49. EM Stouffer HL Petri BD Devan 2004 Effect of D-serine on a delayed match-to-place task for the water maze Behav Brain Res 152 447 452 15196813 10.1016/j.bbr.2003.10.008 1:CAS:528:DC%2BD2cXkvVKku7o%3D (Pubitemid 38757916)
50. B Sunyer S Patil C Frischer H Hoeger G Lubec 2008 Strain-dependent effects of cognitive enhancers in the mouse Amino Acids 34 485 495 17690951 10.1007/s00726-007-0511-6 1:CAS:528:DC%2BD1cXkvVOrsrw%3D (Pubitemid 351569755)
51. GE Tsai PY Lin 2010 Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis Curr Pharm Des 5 522 537 10.2174/138161210790361452
52. G Tsai P Yang L-C Chung N Lange JT Coyle 1998 D-Serine added to antipsychotics for the treatment of schizophrenia Biol Psychiatry 44 1081 1089 9836012 10.1016/S0006-3223(98)00279-0 1:CAS:528:DyaK1cXnvFKqurs%3D (Pubitemid 28547143)
53. HJ Tuominen J Tiihonen K Wahlbeck 2005 Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis Schizophr Res 72 225 234 15560967 10.1016/j.schres.2004.05.005 (Pubitemid 39550993)
54. C Vargas-Lopes C Madeira SA Kahn I Albino do Couto P Bado JC Houzel J De Miranda MS de Freitas ST Ferreira R Panizzutti 2011 Protein kinase C activity regulates D-serine availability in the brain J Neurochem 116 281 290 21070240 10.1111/j.1471-4159.2010.07102.x 1:CAS:528:DC%2BC3MXhtFGqtbY%3D
55. A Werner-Seidler R Richardson 2007 Effects of D-cycloserine on extinction: consequences of prior exposure to imipramine Biol Psychiatry 62 1195 1197 17555721 10.1016/j.biopsych.2007.04.010 1:CAS:528:DC%2BD2sXht1KgtrfL (Pubitemid 350029724)
56. BD Winters TJ Bussey 2005 Glutamate receptors in perirhinal cortex mediate encoding, retrieval, and consolidation of object recognition memory J Neurosci 25 4243 4251 15858050 10.1523/JNEUROSCI.0480-05.2005 1:CAS:528:DC%2BD2MXktFKgtrY%3D (Pubitemid 40628768)
57. Y Yang W Ge Y Chen JM Zhang Y Chen CP Wu MM Poo S Duan 2003 Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine Proc Natl Acad Sci USA 100 15194 15199 14638938 10.1073/pnas.2431073100 1:CAS:528:DC%2BD3sXpvFaqu7g%3D (Pubitemid 37518039)
58. JW Young SB Powell V Risbrough HM Marston MA Geyer 2009 Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia Pharmacol Ther 122 150 202 19269307 10.1016/j.pharmthera.2009.02. 004 1:CAS:528:DC%2BD1MXkslyktrw%3D
59. Z Zhang N Gong W Wang L Xu T-L Xu 2008 Bell-shaped D-serine actions on hippocampal long-term depression and spatial memory retrieval Cereb Cortex 18 2391 2401 18281302 10.1093/cercor/bhn008
60. A Zlomuzica SM De Souza J Huston E Dere 2007 NMDA receptor modulation by D-cycloserine promotes episodic-like memory in mice Psychopharmacology 193 503 509 17497136 10.1007/s00213-007-0816-x 1:CAS:528:DC%2BD2sXotVWmurk%3D (Pubitemid 47094381)